FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386836224> ?p ?o ?g. }

• W4386836224 abstract "Wear particle‑induced osteolysis is a serious complication that occurs in individuals with titanium (Ti)‑based implants following long‑term usage due to loosening of the implants. The control of excessive osteoclast differentiation and inflammation is essential for protecting against wear particle‑induced osteolysis. The present study evaluated the effect of britanin, a pseudoguaianolide sesquiterpene isolated from Inula japonica, on osteoclastogenesis in vitro and Ti particle‑induced osteolysis in vivo. The effect of britanin was examined in the osteoclastogenesis of mouse bone marrow‑derived macrophages (BMMs) using TRAP staining, RT‑PCR, western blotting and immunocytochemistry. The protective effect of britanin was examined in a mouse calvarial osteolysis model and evaluated using micro‑CT and histomorphometry. Britanin inhibited osteoclast differentiation and F‑actin ring formation in the presence of macrophage colony‑stimulating factor and receptor activator of nuclear factor kB ligand in BMMs. The expression of osteoclast‑specific marker genes, including tartrate‑resistant acid phosphatase, cathepsin K, dendritic cell‑specific transmembrane protein, matrix metallopeptidase 9 and nuclear factor of activated T‑cells cytoplasmic 1, in the BMMs was significantly reduced by britanin. In addition, britanin reduced the expression of B lymphocyte‑induced maturation protein‑1, which is a transcriptional repressor of negative osteoclastogenesis regulators, including interferon regulatory factor‑8 and B‑cell lymphoma 6. Conversely, britanin increased the expression levels of anti‑oxidative stress genes, namely nuclear factor erythroid‑2‑related factor 2, NAD(P)H quinone oxidoreductase 1 and heme oxygenase 1 in the BMMs. Furthermore, the administration of britanin significantly reduced osteolysis in a Ti particle‑induced calvarial osteolysis mouse model. Based on these findings, it is suggested that britanin may be a potential therapeutic agent for wear particle‑induced osteolysis and osteoclast‑associated disease." @default.
• W4386836224 created "2023-09-19" @default.
• W4386836224 creator A5015429226 @default.
• W4386836224 creator A5024321339 @default.
• W4386836224 creator A5024591702 @default.
• W4386836224 creator A5032431059 @default.
• W4386836224 creator A5080558481 @default.
• W4386836224 creator A5081828653 @default.
• W4386836224 creator A5085010633 @default.
• W4386836224 creator A5086102838 @default.
• W4386836224 date "2023-09-18" @default.
• W4386836224 modified "2023-10-02" @default.
• W4386836224 title "Britanin inhibits titanium wear particle‑induced osteolysis and osteoclastogenesis" @default.
• W4386836224 cites W1509994947 @default.
• W4386836224 cites W1556517592 @default.
• W4386836224 cites W1904752902 @default.
• W4386836224 cites W1927321941 @default.
• W4386836224 cites W1967502057 @default.
• W4386836224 cites W1974120192 @default.
• W4386836224 cites W1979999123 @default.
• W4386836224 cites W1990028531 @default.
• W4386836224 cites W1993418159 @default.
• W4386836224 cites W2002831974 @default.
• W4386836224 cites W2012815797 @default.
• W4386836224 cites W2017372504 @default.
• W4386836224 cites W2019795889 @default.
• W4386836224 cites W2075753266 @default.
• W4386836224 cites W2076382804 @default.
• W4386836224 cites W2093252878 @default.
• W4386836224 cites W2095495147 @default.
• W4386836224 cites W2096542991 @default.
• W4386836224 cites W2101886066 @default.
• W4386836224 cites W2105828700 @default.
• W4386836224 cites W2107277218 @default.
• W4386836224 cites W2131980428 @default.
• W4386836224 cites W2139628971 @default.
• W4386836224 cites W2146565196 @default.
• W4386836224 cites W2156222682 @default.
• W4386836224 cites W2192080449 @default.
• W4386836224 cites W2334372810 @default.
• W4386836224 cites W2400688846 @default.
• W4386836224 cites W2462317045 @default.
• W4386836224 cites W2574256395 @default.
• W4386836224 cites W2594903447 @default.
• W4386836224 cites W2619930581 @default.
• W4386836224 cites W2884481535 @default.
• W4386836224 cites W2886823378 @default.
• W4386836224 cites W2905588678 @default.
• W4386836224 cites W2928238096 @default.
• W4386836224 cites W2942008644 @default.
• W4386836224 cites W2963301415 @default.
• W4386836224 cites W3000501206 @default.
• W4386836224 cites W3007287953 @default.
• W4386836224 cites W3012417792 @default.
• W4386836224 cites W3048795921 @default.
• W4386836224 cites W3082263723 @default.
• W4386836224 cites W3094259563 @default.
• W4386836224 cites W3207413163 @default.
• W4386836224 cites W3216444202 @default.
• W4386836224 cites W4281297962 @default.
• W4386836224 cites W4296743025 @default.
• W4386836224 cites W4381663110 @default.
• W4386836224 doi "https://doi.org/10.3892/mmr.2023.13092" @default.
• W4386836224 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37732549" @default.
• W4386836224 hasPublicationYear "2023" @default.
• W4386836224 type Work @default.
• W4386836224 citedByCount "0" @default.
• W4386836224 crossrefType "journal-article" @default.
• W4386836224 hasAuthorship W4386836224A5015429226 @default.
• W4386836224 hasAuthorship W4386836224A5024321339 @default.
• W4386836224 hasAuthorship W4386836224A5024591702 @default.
• W4386836224 hasAuthorship W4386836224A5032431059 @default.
• W4386836224 hasAuthorship W4386836224A5080558481 @default.
• W4386836224 hasAuthorship W4386836224A5081828653 @default.
• W4386836224 hasAuthorship W4386836224A5085010633 @default.
• W4386836224 hasAuthorship W4386836224A5086102838 @default.
• W4386836224 hasBestOaLocation W43868362241 @default.
• W4386836224 hasConcept C101990758 @default.
• W4386836224 hasConcept C141071460 @default.
• W4386836224 hasConcept C153911025 @default.
• W4386836224 hasConcept C170493617 @default.
• W4386836224 hasConcept C180675623 @default.
• W4386836224 hasConcept C185592680 @default.
• W4386836224 hasConcept C2776033226 @default.
• W4386836224 hasConcept C2779428903 @default.
• W4386836224 hasConcept C2781282405 @default.
• W4386836224 hasConcept C502942594 @default.
• W4386836224 hasConcept C55493867 @default.
• W4386836224 hasConcept C71924100 @default.
• W4386836224 hasConcept C86803240 @default.
• W4386836224 hasConcept C88045685 @default.
• W4386836224 hasConcept C95444343 @default.
• W4386836224 hasConceptScore W4386836224C101990758 @default.
• W4386836224 hasConceptScore W4386836224C141071460 @default.
• W4386836224 hasConceptScore W4386836224C153911025 @default.
• W4386836224 hasConceptScore W4386836224C170493617 @default.
• W4386836224 hasConceptScore W4386836224C180675623 @default.
• W4386836224 hasConceptScore W4386836224C185592680 @default.
• W4386836224 hasConceptScore W4386836224C2776033226 @default.
• W4386836224 hasConceptScore W4386836224C2779428903 @default.

• next